Sort
17,288 grants matching “multiple sclerosis”
Neuroprotective role of vitamin D during childhood
$192,500Amy E Lovett-Racke · Ohio State University · R21 · FY2017 · HD
Mechanisms of neuron-oligodendrocyte precursor cell interactions
$192,500Kelly R Monk · Oregon Health & Science University · R21 · FY2022 · NS
Mechanisms of C9orf72-associated dipeptide toxicity
$192,500Samuel T Lamitina · University Of Pittsburgh At Pittsburgh · R21 · FY2016 · NS
Epileptogenesis in a rat model of tuberous sclerosis
$192,476University Of Washington · R21 · FY2003 · NS
Epileptogenesis in a rat model of tuberous sclerosis
$192,476University Of Washington · R21 · FY2002 · NS
Characterizing axonal damage in multiple sclerosis using TractCaliber MRI
$192,421Susie Yi Huang · Massachusetts General Hospital · K23 · FY2016 · NS
ROLE OF T CELLS IN THE IMMUNE MODULATION OF MS
$192,369Nitin J Karandikar · University Of Iowa · R01 · FY2011 · AI
Regulation of paraspeckles by STAU1 in neurodegenerative disease
$192,344Daniel R Scoles · University Of Utah · R21 · FY2023 · NS
Racial Disparities in Multiple Sclerosis: Quality of Care and Patient Experiences
$192,343Jagriti Jackie Bhattarai · Johns Hopkins University · K23 · FY2019 · MD
MODULATION OF ABETA PEPTIDE ACCUMULATION AND NEURON DAMAGE IN VIVO WITH ADULT BON
$192,312Christopher D Keene · University Of Washington · P50 · FY2014 · AG
Obesity as a Driver of Inflammation and Brain Volume Loss in Pediatric Multiple Sclerosis
$192,301James Nicholas Brenton · University Of Virginia · K23 · FY2023 · NS
Leveraging Myelin-Sensitive Imaging to Predict Early Lesion Pathogenesis in Cerebral Adrenoleukodystrophy
$192,283Eric Mallack · Hugo W. Moser Res Inst Kennedy Krieger · K23 · FY2024 · NS
Axonal degeneration can trigger demyelinating disease
$192,281Ikuo Tsunoda · Louisiana State Univ Hsc Shreveport · R21 · FY2009 · NS
Complement protection and anaphylatoxins in neuroinflammation
$192,281Brian K Martin · Iowa Cancer Research Foundation, Inc. · R21 · FY2009 · NS
Measuring Sensitivity to Nonignorability
$192,221University Of Pennsylvania · R01 · FY2002 · HL
Measuring Sensitivity to Nonignorability
$192,221University Of Pennsylvania · R01 · FY2003 · HL
Novel Therapies for Epilepsy Using Biodegradable Immune-Modifying Nanoparticles
$192,155Stephen D Miller · Northwestern University At Chicago · R21 · FY2016 · NS
Mapping HIV-Tat +/- endocannabinoid induced synaptic changes at the macromolecular level via cryo-electron tomography
$192,138Sylvia Fitting · Univ Of North Carolina Chapel Hill · R21 · FY2019 · DA
Racial Disparities in Multiple Sclerosis: Quality of Care and Patient Experiences
$192,136Jagriti Jackie Bhattarai · Johns Hopkins University · K23 · FY2020 · MD
The Role of Complement in Cerebrospinal Fluid Shunt Infections
$192,132Gwenn L Skar · University Of Nebraska Medical Center · K08 · FY2023 · NS
The Role of Complement in Cerebrospinal Fluid Shunt Infections
$192,132Gwenn L Skar · University Of Nebraska Medical Center · K08 · FY2020 · NS
The Role of Complement in Cerebrospinal Fluid Shunt Infections
$192,132Gwenn L Skar · University Of Nebraska Medical Center · K08 · FY2021 · NS
Administrative Core - Mental Retardation and Developmental Disabilities Research
$192,024Michael E Greenberg · Boston Children'S Hospital · P30 · FY2008 · HD
Administrative Core - Mental Retardation and Developmental Disabilities Research
$192,023Michael E Greenberg · Boston Children'S Hospital · P30 · FY2008 · HD
Mode of action of a neuroprotective compound
$192,000Corinne Ida Lasmezas · Scripps Florida · R21 · FY2017 · NS